A Philadelphia court has ordered the German giant to compensate a Pennsylvania man who used the herbicide Roundup. The stock is near its 2010 lows
Btp Value on offer until Friday. Rate cut, eyes on the Milan Fed. Milan black top in the EU, managed savings securities suffer. Oil companies are doing well
GDP down in 2023, auto industry in severe pain, Bayer in crisis and struggling with cuts. An aspirin won't be enough to cure the country. And an economy that is struggling to grow fuels social conflicts: a threat at the heart of the EU
Bayer has suspended a study on an anticoagulant drug considered essential and has received a US order to pay a huge compensation of 1,5 billion for the herbicide Roundup
Despite the leap of Stm and the new exploit of Banco Bpm which pushed the Ftse Mib into positive territory (+0,2%), the markets remain fragile and volatile due to the concurrence of at least four elements of uncertainty
Approved a regional law to prevent farmers and companies from using the substance with possible carcinogenic effects - Local administrations continue to move in random order and the Government is late
The California court has recognized the "significant factor" of the herbicide Roundup in the illness of a couple with cancer and set a compensation of 2 billion - Stock market knockout.
The collapse of BMW and the retracement of FCA hit the stocks of the entire automotive sector while the collapse of Bayer (-10%) above all sinks the Frankfurt stock market - Piazza Affari limits the damage (-0,4%) despite the losses …
The collapse of the chemical stock and the German car accounts send the Dax down - FCA also down after the rally at the beginning of the week - Oil and luxury goods down - Bene Poste, Buzzi in evidence - The…
In total, the group employees are now 118 - Part of the freed up resources should be used to strengthen the innovation and competitiveness of the various divisions of the group.
The 289 million fine imposed on Monsanto for the accusation of causing cancer in a gardener through the use of glyphosate could be reduced - It is also possible that the trial will be re-tried
Piazza Affari is still the worst stock exchange today, dragged down by the banks suffering from the Turkish crisis and the rise in the Btp-Bund spread - The collapse of Bayer (-11%) aggravates the performance of the lists - Azimut, Unipol go against the trend Moncler and…
The German giant comes to lose more than 10% on the Frankfurt Stock Exchange after a US court sentenced Monsanto (a company with which Bayer recently completed the merger) to pay 289 million to a gardener who allegedly…
From June 7 Monsanto brand will disappear and its products will be sold only under their trademark - One of the biggest mergers in recent years completed - Bayer expects positive contribution to basic earnings per share…
With this sale worth over 1,7 billion, the German giant satisfies the conditions set by the EU Antitrust to grant the go-ahead for the purchase of the US group - The agreement with BASF includes the transfer of 2.500 employees
As happened a few weeks ago with the go-ahead from Brussels, also in this case the green light is "conditional" - The Bayer stock soars on the Dax 30, gaining more than 5%.
Competition Commissioner Margrethe Vestager has given the green light to the operation as long as "the broad remedies proposed to eliminate the EU's doubts about overlaps in the seed, pesticide and digital agriculture markets are implemented" - This is why Bayer is about to give up…
This was announced by the German group saying it is confident that, through this operation, it will meet the concerns of the European Commission, which has frozen the merger with the American Monsanto.
The German group sells the agrochemical activities to facilitate the union with Monsanto after the EU reliefs. The Union will decide by 8 January 2018
The Bayer-Monsanto merger would create, warns the EU Antitrust, the world's largest integrated company of pesticides and seeds, seriously endangering competition on that market - The final decision by 8 January.
In the first quarter, the German giant saw profits grow by 38%, to 2,1 billion euros, a result that allows it to raise its estimates for the entire year - The Swiss group, on the other hand, recorded a turnover higher than forecasts…
Profits of the German chemical giant have reached 4,5 billion - Turnover is also growing - Positive fourth quarter but below estimates.
The 66 billion merger between Bayer and Monsanto, the run of Apple which returns above 600 billion and the turnaround in Mps with the arrival of Morelli attract the spotlights of the market - Investors lighten their positions on stocks…
After so many refusals, the American giant accepts the latest offer from the German giant, which comes to put on the plate 128 dollars per share - Now we have to overcome the launch of the Antitrust authorities, but for Bayer there is also the risk of a…
Changing of the guard today at Montepaschi with the appointment of Marco Morelli as new CEO - No IPO2 for Poste - Generous withdrawals for Bpm and Banco Pop in view of the merger - Cannata: public needs financed before…
The group is preparing the sale of the dermatology division. Bloomberg's indiscretion causes the stock to slide on the Stock Exchange
The Germans raise their offer for Monsanto up to 135 dollars per share and breach the heart of the American agribusiness giant - The next few weeks will be decisive: if the final negotiations go through, the world leader in pesticides will be born…
According to the German newspaper Handelsblatt, Bayer is expected to make a decision in the coming weeks as the discussions are at a decisive stage.
The American agrochemical group once again rejects the offer of the German pharmaceutical giant: the board of directors judged the 64 billion dollar proposal "inadequate".
The cash offer for the acquisition of the American group has been raised from 122 to 125 dollars per share - The Germans will pay Monsanto 1,5 billion dollars if the combination were to fall apart for antitrust reasons.
The Board of the American agrochemical group considers the proposal "incomplete and financially inadequate, but is open to continuing constructive discussions to understand whether"a transaction that is in the best interests of Monsanto shareholders can be achieved".
The German chemical-pharmaceutical group has announced that it has presented the maxi-offer to take possession of the US agro-chemical company. Here are the details
According to estimates by the Reuters agency, the merger between the German pharmaceutical group and the leading US biotechnology company would give rise to a group with a turnover of approximately 60 billion euros.
According to Bloomberg, the German giant is studying the purchase of the US agrochemical multinational, valued at around 40 billion - Bayer slips on the Stock Exchange, Monsanto flies to Wall Street.
A challenge, the one against the Bavarians, which will be played in a sold out Olimpico, which will offer a spectacular glance with 70 people and three and a half million in proceeds.
Sports director Walter Sabatini therefore satisfied the Moroccan defender who had long asked the Capitoline club to be able to play in a top club and the one led by Pep Guardiola represents the opportunity of a lifetime.
The German pharmaceutical giant closed the first quarter of the year with an adjusted ebitda of 2,45 billion (+0,4%), slightly below analysts' expectations - Revenues up by 2,1% and net profit by 11,5 .1,26% to XNUMX billion - Confirmed the…